Kenvue Layoffs Sign Ongoing Restructuring and Doable Divestment of Magnificence Manufacturers

THE WHAT? Kenvue, the Johnson & Johnson client well being spin-off, is transferring ahead with one other spherical of layoffs, slicing 69 jobs at its new Summit, New Jersey headquarters. The cuts are a part of a broader restructuring initiative that features workforce reductions, model consolidation, and a possible divestment of choose pores and skin well being and sweetness labels.

THE DETAILS  

• The 69 layoffs will happen between October 10 and December 19, based on a submitting with New Jersey’s Division of Labor.
• This follows earlier job cuts, together with 51 roles in 2023 and 84 positions tied to the relocation of Neutrogena from California to New Jersey.
• Kenvue has introduced plans to cut back its world workforce by 4%, focusing on US$350 million in annual financial savings by 2026.
• Sources informed Reuters the corporate is exploring the sale of a number of underperforming pores and skin and sweetness manufacturers, together with Clear & Clear and Maui Moisture, which collectively generate over US$500 million in income.
• The corporate’s core magnificence manufacturers, akin to Neutrogena and Aveeno, are anticipated to stay central to its long-term technique.

THE WHY? The layoffs and potential divestments spotlight continued post-separation restructuring at Kenvue. As the corporate narrows its focus, the pores and skin well being and sweetness class — lengthy a progress driver inside client well being — is being reevaluated for strategic match and profitability. Manufacturers not aligned with Kenvue’s future course could also be offloaded, which may alter the aggressive panorama in mass magnificence and private care. Whereas core franchises like Neutrogena stay intact, the reshuffling raises questions on scale, model focus, and margin expectations throughout the broader portfolio.

Supply: NJBIZ